Cargando…

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer

BACKGROUND: Radical prostatectomy is used to treat patients with clinically localized prostate cancer, but there have been few reports of its use in locally advanced disease. We evaluated the long-term results of radical prostatectomy and immediate adjuvant androgen deprivation therapy in Japanese p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Yuzuri Tsurumaki, Fukuhara, Hiroshi, Suzuki, Motofumi, Fujimura, Tetsuya, Nakagawa, Tohru, Nishimatsu, Hiroaki, Kume, Haruki, Morikawa, Teppei, Fukayama, Masashi, Homma, Yukio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912934/ https://www.ncbi.nlm.nih.gov/pubmed/24476554 http://dx.doi.org/10.1186/1471-2490-14-13

Ejemplares similares

Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer
por: Taguchi, Satoru, et al.
Publicado: (2014)

Multiple primary malignant neoplasms of the glottis, renal pelvis, urinary bladder, oral floor, prostate, and esophagus in a Japanese male patient: a case report
por: Mukaiyama, Yoshihiro, et al.
Publicado: (2014)

Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy
por: Yamada, Yuta, et al.
Publicado: (2017)

Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality
por: Taguchi, Satoru, et al.
Publicado: (2015)

Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
por: Taguchi, Satoru, et al.
Publicado: (2016)

Adenocarcinoma at Anastomotic Site of Ureterosigmoidostomy Potentially of Urothelial Origin Spreading to the Upper Urinary Tract
por: Makino, Katsuhiro, et al.
Publicado: (2015)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Preoperative Evaluation of Renal Cell Carcinoma by Using 18F-FDG PET/CT
por: Takahashi, Miwako, et al.
Publicado: (2015)

Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model
por: Taguchi, Satoru, et al.
Publicado: (2020)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Robot-assisted versus other types of radical prostatectomy: Population-based safety and cost comparison in Japan, 2012–2013
por: Sugihara, Toru, et al.
Publicado: (2014)

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
por: Taguchi, Satoru, et al.
Publicado: (2017)

Lipid Cell and Micropapillary Variants of Urothelial Carcinoma of the Ureter
por: Miyama, Yu, et al.
Publicado: (2015)

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
por: Fujimura, Tetsuya, et al.
Publicado: (2015)

Adenoma-carcinoma Sequence in the Bladder After Augmentation Cystoplasty
por: Naito, Akihiro, et al.
Publicado: (2014)

A rare case of de novo large cell neuroendocrine carcinoma of the prostate with long-term survival after cystoprostatectomy and androgen deprivation
por: Miyakawa, Jimpei, et al.
Publicado: (2018)

Intrascrotal Dedifferentiated Leiomyosarcoma Originating from Dartos Muscle
por: Teshima, Taro, et al.
Publicado: (2014)

Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice
por: Nishimatsu, Hiroaki, et al.
Publicado: (2015)

Metastatic Small Intestinal Cancer of the Urinary Bladder
por: Morikawa, Teppei, et al.
Publicado: (2010)

Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12
por: Fukuhara, Hiroshi, et al.
Publicado: (2023)

Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor
por: Yamada, Yuta, et al.
Publicado: (2016)

A Case of Urinary Bladder Urothelial Carcinoma with Squamous, Glandular, and Plasmacytoid Differentiation
por: Makise, Naohiro, et al.
Publicado: (2014)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count
por: Miyama, Yu, et al.
Publicado: (2018)

Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy
por: Yamada, Yuta, et al.
Publicado: (2020)

Preservation of pelvic floor muscles contributes to early continence recovery after robot-assisted radical prostatectomy
por: Nakamura, Masaki, et al.
Publicado: (2022)

Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
por: Taguchi, Satoru, et al.
Publicado: (2021)

Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
por: Kawai, Taketo, et al.
Publicado: (2022)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients
por: Liu, Jinan, et al.
Publicado: (2013)

Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy
por: Shin, Dongseong, et al.
Publicado: (2020)

Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
por: Han, Sujun, et al.
Publicado: (2023)

Development of Nephrotic Syndrome after Administration of Sorafenib in a Case of Metastatic Renal Cell Carcinoma
por: Okuno, Yumiko, et al.
Publicado: (2011)

Attenuated lipopolysaccharide-induced inflammatory bladder hypersensitivity in mice deficient of transient receptor potential ankilin1
por: Kamei, Jun, et al.
Publicado: (2018)

Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2016)

Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
por: Li, Xuwen, et al.
Publicado: (2023)

Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old
por: Blas, Leandro, et al.
Publicado: (2021)

Left testicular and pulmonary metastases of mucinous adenocarcinoma of the prostate after robot‐assisted radical prostatectomy
por: Kato, Kisumi, et al.
Publicado: (2023)

Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy
por: Maru, Shintaro, et al.
Publicado: (2018)

Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19
por: Sean Ong, Xuan Rui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t4ia300hp1ik8u0k6kncut4mcc